We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Oscar Health Membership Surges but Profitability Remains Key
Read MoreHide Full Article
Key Takeaways
Oscar Health's membership rose 46% year over year to 2.96 million as of June 30, 2026.
Oscar Health plans to enter more than 150 additional metropolitan statistical areas by 2027.
OSCR shares gained 109% year to date, while its price-to-book multiple of 4.5 topped the industry average.
Oscar Health (OSCR - Free Report) is a healthcare technology company built around a full-stack platform and a strong focus on member experience. Membership reached 2.96 million at the end of the second quarter of 2026, up 46% year over year, driven by above-market growth during open enrollment and solid retention. The performance indicates growing acceptance of Oscar’s products, geographic footprint and technology-enabled model in the Affordable Care Act marketplace. Moreover, the gains came despite weaker overall paid ACA enrollment following the expiration of enhanced subsidies, suggesting that Oscar captured market share rather than simply benefiting from industry growth.
Several structural opportunities could support further expansion. Also, Oscar plans to enter more than 150 additional metropolitan statistical areas by 2027, widening its addressable market. Individual Coverage Health Reimbursement Arrangements offer another potential enrollment channel. The company’s strategy also aligns with major healthcare trends, including rising costs, consumerization, digitization and demand for more personalized care, potentially strengthening its long-term competitive position.
However, enrollment remains seasonal. Although Oscar added roughly 1.1 million members during the first quarter of 2026, membership subsequently declined on a sequential basis as the annual enrollment effect faded. Higher premiums and reduced subsidies could also drive price-sensitive consumers, particularly younger and healthier individuals, out of the market. Oscar must therefore price its plans carefully while managing rising medical utilization.
A shift toward slower, more sustainable growth would not weaken the investment thesis if profitability and cash generation improve. It is better to focus on prioritizing retention, medical-loss-ratio stability, risk-adjustment trends and disciplined geographic expansion over headline membership growth.
What About Peers?
Molina Healthcare (MOH - Free Report) is well positioned to benefit from several long-term trends supporting government-sponsored healthcare. As of June 30, 2026, total membership of Molina Healthcare decreased 14.3% year over year to around 4.9 million. Rising healthcare utilization, an aging U.S. population and strategic shift toward D-SNPs should support sustained membership growth for Molina Healthcare.
Centene Corporation (CNC - Free Report) has shifted its strategy from prioritizing membership growth to improving earnings quality through disciplined pricing and portfolio optimization. Centene continues to benefit from a large and diversified membership base supported by contract wins and expansion in attractive government-sponsored programs. Centene is also shifting toward higher-quality membership, including growing PDP and dual-eligible Medicare exposure.
OSCR’s Price Performance
Shares of Oscar Health have gained 108.6% year to date, outperforming the industry.
Image Source: Zacks Investment Research
OSCR’s Expensive Valuation
The stock is overvalued compared with its industry. It is currently trading at a price-to-book multiple of 4.5, higher than the industry average of 2.67.
Image Source: Zacks Investment Research
Estimate Movement for OSCR
The Zacks Consensus Estimate for OSCR’s third-quarter 2026 earnings per share (EPS) witnessed southbound movement in the last 30 days, while that for fourth-quarter witnessed no movement in the same time frame. The consensus estimate for 2026 and 2027 earnings has moved 144.4% and 31.6% north, respectively, in the past 30 days.
Image Source: Zacks Investment Research
The consensus estimates for OSCR’s 2026 and 2027 revenues and earnings indicate year-over-year decreases.
View the Zacks #1 Rank List
Image: Bigstock
Oscar Health Membership Surges but Profitability Remains Key
Key Takeaways
Oscar Health (OSCR - Free Report) is a healthcare technology company built around a full-stack platform and a strong focus on member experience. Membership reached 2.96 million at the end of the second quarter of 2026, up 46% year over year, driven by above-market growth during open enrollment and solid retention. The performance indicates growing acceptance of Oscar’s products, geographic footprint and technology-enabled model in the Affordable Care Act marketplace. Moreover, the gains came despite weaker overall paid ACA enrollment following the expiration of enhanced subsidies, suggesting that Oscar captured market share rather than simply benefiting from industry growth.
Several structural opportunities could support further expansion. Also, Oscar plans to enter more than 150 additional metropolitan statistical areas by 2027, widening its addressable market. Individual Coverage Health Reimbursement Arrangements offer another potential enrollment channel. The company’s strategy also aligns with major healthcare trends, including rising costs, consumerization, digitization and demand for more personalized care, potentially strengthening its long-term competitive position.
However, enrollment remains seasonal. Although Oscar added roughly 1.1 million members during the first quarter of 2026, membership subsequently declined on a sequential basis as the annual enrollment effect faded. Higher premiums and reduced subsidies could also drive price-sensitive consumers, particularly younger and healthier individuals, out of the market. Oscar must therefore price its plans carefully while managing rising medical utilization.
A shift toward slower, more sustainable growth would not weaken the investment thesis if profitability and cash generation improve. It is better to focus on prioritizing retention, medical-loss-ratio stability, risk-adjustment trends and disciplined geographic expansion over headline membership growth.
What About Peers?
Molina Healthcare (MOH - Free Report) is well positioned to benefit from several long-term trends supporting government-sponsored healthcare. As of June 30, 2026, total membership of Molina Healthcare decreased 14.3% year over year to around 4.9 million. Rising healthcare utilization, an aging U.S. population and strategic shift toward D-SNPs should support sustained membership growth for Molina Healthcare.
Centene Corporation (CNC - Free Report) has shifted its strategy from prioritizing membership growth to improving earnings quality through disciplined pricing and portfolio optimization. Centene continues to benefit from a large and diversified membership base supported by contract wins and expansion in attractive government-sponsored programs. Centene is also shifting toward higher-quality membership, including growing PDP and dual-eligible Medicare exposure.
OSCR’s Price Performance
Shares of Oscar Health have gained 108.6% year to date, outperforming the industry.
Image Source: Zacks Investment Research
OSCR’s Expensive Valuation
The stock is overvalued compared with its industry. It is currently trading at a price-to-book multiple of 4.5, higher than the industry average of 2.67.
Image Source: Zacks Investment Research
Estimate Movement for OSCR
The Zacks Consensus Estimate for OSCR’s third-quarter 2026 earnings per share (EPS) witnessed southbound movement in the last 30 days, while that for fourth-quarter witnessed no movement in the same time frame. The consensus estimate for 2026 and 2027 earnings has moved 144.4% and 31.6% north, respectively, in the past 30 days.
Image Source: Zacks Investment Research
The consensus estimates for OSCR’s 2026 and 2027 revenues and earnings indicate year-over-year decreases.
OSCR stock currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.